- $236.06m
- $815.99m
- $734.67m
- 75
- 92
- 47
- 82
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 540 | 877 | 1,062 | 632 | 735 |
Cost of Revenue | |||||
Gross Profit | 370 | 678 | 823 | 444 | 576 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 572 | 942 | 1,564 | 950 | 816 |
Operating Profit | -32.8 | -64.5 | -501 | -319 | -81.7 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -41.1 | -97.2 | -534 | -376 | -151 |
Provision for Income Taxes | |||||
Net Income After Taxes | -41.1 | -97.2 | -534 | -376 | -151 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -41.1 | -44.3 | -189 | -149 | -63.3 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -41.1 | -18.8 | -189 | -149 | -63.3 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -2.2 | -3.26 | 9.87 | -14.2 | -5.92 |